QUREuniQure N.V.

CSNasdaq (XNAS)·USD

Identity

Security key: 20736
Ticker: QURE
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2014-02-05
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: QURE

Detail

Enriched 2026-08-14 20:47

Market cap: $3,130,506,173.56
Shares outstanding (class): 69,366,412
Shares outstanding (weighted): 69,366,412
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 221
Location: AMSTERDAM
Homepage: https://www.uniqure.com
Description: uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Market cap and share counts drift.

Funds holding this security

32 funds · 37 positions · $176.71M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
abrdn Healthcare Investors —	—	$34.24M	3.01%	2,094,039 NS	TICKER
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$27.75M	0.37%	1,697,402 NS	TICKER
abrdn World Healthcare Fund —	—	$20.81M	4.33%	1,272,580 NS	TICKER
abrdn Life Sciences Investors —	—	$15.91M	2.84%	972,920 NS	TICKER
abrdn Healthcare Opportunities Fund —	—	$15.81M	2.19%	966,847 NS	TICKER
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$11.35M	0.01%	694,353 NS	TICKER
JPMorgan Growth Advantage Fund J.P. Morgan Mutual Fund Investment Trust	—	$9.22M	0.05%	564,195 NS	TICKER
JPMorgan Mid Cap Growth Fund JPMorgan Trust II	—	$9.22M	0.08%	563,654 NS	TICKER
iShares Biotechnology ETF iShares Trust	IBB	$6.76M	0.08%	413,699 NS	TICKER
JPMorgan Small Cap Growth Fund JPMorgan Trust II	—	$6.28M	0.29%	384,373 NS	TICKER
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$4.22M	0.63%	258,211 NS	TICKER
JNL/JPMorgan MidCap Growth Fund JNL Series Trust	—	$2.53M	0.08%	155,019 NS	TICKER
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$2.19M	0.09%	133,973 NS	TICKER
JPMorgan Small Cap Blend Fund JPMorgan Trust I	—	$2.03M	0.14%	124,090 NS	TICKER
JPMorgan Active Growth ETF J.P. Morgan Exchange-Traded Fund Trust	JGRO	$1.88M	0.02%	114,772 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERQURE
CIK0001590560
ISINNL0010696654
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: uniQure is a gene therapy company, fitting the biotechnology industry within healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.